Symposium co-hosted by the Pharmaceutical Manufacturers Association of Japan (PMAJ) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Report on "G7 Hiroshima Summit: Recommendations for the Health Agenda -Lessons Learned from COVID-19 to Facilitate Progress Toward SDG 3: A Roadmap for Action~.
The Pharmaceutical Manufacturers Association of Japan (PMAJ) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) jointly organized a symposium entitled "Recommendations for the G7 Hiroshima Summit Health Agenda: Leveraging Lessons from COVID-19 to Promote Progress toward SDG3: A Roadmap for Action" on Friday, May 12, 2023 from 16:30-18:30. The conference was held on Friday, May 12, 2023, from 16:30 to 18:30.
Inviting leading figures in health policy and system building in Japan and internationally, we aimed to deepen discussion on international health challenges and solutions for the post-coronary era, and to disseminate the contents of the conference widely.
The symposium is also introduced on the website of IFPMA, the co-sponsor of the symposium.
Proposals for the G7 Hiroshima Summit Health Agenda - IFPMA
Program
Agenda Overview
Article Ads
G7 Hiroshima Summit: "Recommendations for the Health Agenda"
Newspaper and Magazine Advertisements | Video Content and Advertisements from the Pharmaceutical Manufacturers Association of Japan (jpma.or.jp)